CAS 2213-63-0|2,3-Dichloroquinoxaline
| Common Name | 2,3-Dichloroquinoxaline | ||
|---|---|---|---|
| CAS Number | 2213-63-0 | Molecular Weight | 199.037 |
| Density | 1.5±0.1 g/cm3 | Boiling Point | 269.7±35.0 °C at 760 mmHg |
| Molecular Formula | C8H4Cl2N2 | Melting Point | 152-154 °C(lit.) |
| MSDS | ChineseUSA | Flash Point | 142.9±11.5 °C |
| Symbol | GHS06 | Signal Word | Danger |
Names
| Name | 2,3-Dichloroquinoxaline |
|---|---|
| Synonym | More Synonyms |
Chemical & Physical Properties
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Boiling Point | 269.7±35.0 °C at 760 mmHg |
| Melting Point | 152-154 °C(lit.) |
| Molecular Formula | C8H4Cl2N2 |
| Molecular Weight | 199.037 |
| Flash Point | 142.9±11.5 °C |
| Exact Mass | 197.975159 |
| PSA | 25.78000 |
| LogP | 3.04 |
| Vapour Pressure | 0.0±0.5 mmHg at 25°C |
| Index of Refraction | 1.671 |
| InChIKey | SPSSDDOTEZKOOV-UHFFFAOYSA-N |
| SMILES | Clc1nc2ccccc2nc1Cl |
| Stability | Stable. Incompatible with strong oxidizing agents. |
Toxicological Information
CHEMICAL IDENTIFICATION |
ACUTE TOXICITY DATA - TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 195 mg/kg
- TOXIC EFFECTS :
- Behavioral - muscle weakness Gastrointestinal - peritonitis Kidney, Ureter, Bladder - other changes
- REFERENCE :
- NTIS** National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific & Technical Information. Volume(issue)/page/year: OTS0534573
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 5600 ug/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- CSLNX* U.S. Army Armament Research & Development Command, Chemical Systems Laboratory, NIOSH Exchange Chemicals. (Aberdeen Proving Ground, MD 21010) Volume(issue)/page/year: NX#03256
Safety Information
| Symbol | GHS06 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H301-H315-H319-H335 |
| Precautionary Statements | P261-P301 + P310-P305 + P351 + P338 |
| Personal Protective Equipment | Eyeshields;Faceshields;Gloves;type P2 (EN 143) respirator cartridges |
| Hazard Codes | T:Toxic; |
| Risk Phrases | R25;R36/37/38 |
| Safety Phrases | S26-S36/37/39-S45-S37/39-S28A |
| RIDADR | 2811 |
| WGK Germany | 3 |
| RTECS | VD1720000 |
| Packaging Group | III |
| Hazard Class | 6.1 |
Articles5
More Articles| Synthesis of some new pyrimido[2',1':2,3]thiazolo[4,5-b]quinoxaline derivatives as anti-inflammatory and analgesic agents. Eur. J. Med. Chem. 45 , 1976-81, (2010) Treatment of 6-aminothiouracil (1) with 2,3-dichloroquinoxaline (2) in ethanol/TEA afforded 6-amino-2-(3-chloroquinoxalin-2-ylthio)pyrimidin-4(3H)-one (3), which was refluxed in DMF to give 2-aminopyr... | |
| Synthesis, structure elucidation and antibacterial evaluation of new steroidal -5-en-7-thiazoloquinoxaline derivatives. Eur. J. Med. Chem. 43 , 2257-61, (2008) Some heterocyclic systems namely cholest-5-en-7-thiazolo[4,5-b]quinoxaline-2-yl-hydrazone] were synthesized by the reaction of cholest-5-en-7-one-thiosemicarbazone with 2,3-dichloroquinoxaline at 80 d... | |
| AlCl3 induced (hetero)arylation of 2,3-dichloroquinoxaline: a one-pot synthesis of mono/disubstituted quinoxalines as potential antitubercular agents. Bioorg. Med. Chem. 20(5) , 1711-22, (2012) A direct and single-step method has been developed for the synthesis of mono and 2,3-disubstituted quinoxalines by using a AlCl(3) induced (hetero)arylation of 2,3-dichloroquinoxaline. Both symmetrica... |
Synonyms
| 2,3-Dichloroquinoxaline |
| 2,3-DICHLORO-QUINOXALINE |
| 2,3,6-TRIFLUOROBENZOICACID |
| 2,3-dichloroquinoxazoline |
| 2,3-dichloroquinaxoline |
| Quinoxaline,2,3-dichloro |
| Quinoxaline, 2,3-dichloro- |
| EINECS 218-667-3 |
| MFCD00006720 |
| 2,3-dichloro quinoxaline |
